BR9709546A - Formulação e método para tratamento de insuficiéncia cardíaca digestiva - Google Patents

Formulação e método para tratamento de insuficiéncia cardíaca digestiva

Info

Publication number
BR9709546A
BR9709546A BR9709546A BR9709546A BR9709546A BR 9709546 A BR9709546 A BR 9709546A BR 9709546 A BR9709546 A BR 9709546A BR 9709546 A BR9709546 A BR 9709546A BR 9709546 A BR9709546 A BR 9709546A
Authority
BR
Brazil
Prior art keywords
digestive
formulation
treatment
heart failure
heart
Prior art date
Application number
BR9709546A
Other languages
English (en)
Inventor
John Leeper Mcnay Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9709546A publication Critical patent/BR9709546A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9709546A 1996-06-06 1997-06-05 Formulação e método para tratamento de insuficiéncia cardíaca digestiva BR9709546A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65946396A 1996-06-06 1996-06-06
PCT/US1997/009914 WO1997046241A1 (en) 1996-06-06 1997-06-05 Formulation and method for treating congestive heart failure

Publications (1)

Publication Number Publication Date
BR9709546A true BR9709546A (pt) 1999-08-10

Family

ID=24645503

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709546A BR9709546A (pt) 1996-06-06 1997-06-05 Formulação e método para tratamento de insuficiéncia cardíaca digestiva

Country Status (17)

Country Link
EP (1) EP0914128A1 (pt)
JP (1) JP2000511906A (pt)
KR (1) KR20000016406A (pt)
CN (1) CN1226166A (pt)
AU (1) AU3233197A (pt)
BR (1) BR9709546A (pt)
CA (1) CA2256720A1 (pt)
CZ (1) CZ397698A3 (pt)
EA (1) EA199900006A1 (pt)
HU (1) HUP0003885A2 (pt)
IL (1) IL126966A0 (pt)
NO (1) NO985695L (pt)
PL (1) PL330637A1 (pt)
TR (1) TR199802496T2 (pt)
WO (1) WO1997046241A1 (pt)
YU (1) YU55998A (pt)
ZA (1) ZA974978B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815411A1 (de) * 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenese stimulierend wirksame Arzneimittel
WO2000044355A1 (en) * 1999-01-29 2000-08-03 Eli Lilly And Company Moxonidine salts
DE10003771A1 (de) 1999-02-01 2000-08-03 Solvay Pharm Gmbh Arzneimittel zur Behandlung nach Herzinfarkt
DE602006018139D1 (de) * 2006-08-31 2010-12-23 Chemagis Ltd Verwendung der Monoxidinssalze zur Reinigung von Monoxidin
KR100812287B1 (ko) * 2007-01-03 2008-03-13 주식회사 챠콜코리아 내면에 반사층을 갖는 신호등 갓

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal

Also Published As

Publication number Publication date
HUP0003885A2 (hu) 2001-04-28
KR20000016406A (ko) 2000-03-25
AU3233197A (en) 1998-01-05
EA199900006A1 (ru) 1999-06-24
IL126966A0 (en) 1999-09-22
ZA974978B (en) 1998-12-07
TR199802496T2 (xx) 1999-02-22
EP0914128A1 (en) 1999-05-12
WO1997046241A1 (en) 1997-12-11
CZ397698A3 (cs) 1999-05-12
NO985695L (no) 1999-02-04
JP2000511906A (ja) 2000-09-12
NO985695D0 (no) 1998-12-04
YU55998A (en) 1999-11-22
PL330637A1 (en) 1999-05-24
CN1226166A (zh) 1999-08-18
CA2256720A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
NO992769L (no) Fremgangsmåte for behandling og forhindring av hjertesvikt og ventrikulaer dilatasjon
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
BR9702541A (pt) Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético
EP1022945A4 (en) METHOD AND FORMULATION FOR THE TREATMENT OF VASCULAR DISEASES
PT948308E (pt) Metodos para o tratamento de pigmentacao da pele
NO985484D0 (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
NO993066D0 (no) Ny behandling for leddinflammasjon
PT928193E (pt) Utilizacao de 1-hidroxi-2-piridonas para o tratamento de infeccoes da pele
BR9707332A (pt) Método e formulação de revestimento de cura dupla
BR9709546A (pt) Formulação e método para tratamento de insuficiéncia cardíaca digestiva
PT925039E (pt) Aparelhos para tratamento de ortopedia funcional dento facial e parodontologia
EP0699384A3 (en) Material for the treatment of animal excrement and process for its manufacture
BR9710544A (pt) M-todo de tratamento composto e composi-Æo farmac-utica
PT1051172E (pt) Metodo para tratamento da dpco
PL330550A1 (en) Novel aromatic ribose-substituted derivatives, method of obtaining them and their application as therapeutic agents
FI942528A (fi) Kenkä ja menetelmä kengän kiinnittämiseksi
AU7486898A (en) Global medical treatment method and apparatus
PT918521E (pt) Formulacao para o tratamento e/ou profilaxia da demencia
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
NO993196D0 (no) FremgangsmÕte og utstyr for behandling av fjµrkre f°r slakting
UA25399A (uk) Спосіб лікуваhhя хворих гломерулоhефритом

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]